EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹3,861 Cr | ₹3,566 Cr | ₹3,449 Cr | ₹2,737 Cr | ₹2,523 Cr |
What is the latest Total Non-Current Assets ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹3,861 Cr |
| Mar2025 | ₹3,566 Cr |
| Mar2024 | ₹3,449 Cr |
| Mar2023 | ₹2,737 Cr |
| Mar2022 | ₹2,523 Cr |
How is Total Non-Current Assets of EMCURE PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,861 Cr | 8.28 | |
| Mar2025 | ₹3,566 Cr | 3.37 | |
| Mar2024 | ₹3,449 Cr | 26.01 | |
| Mar2023 | ₹2,737 Cr | 8.49 | |
| Mar2022 | ₹2,523 Cr | - | |
Compare Total Non-Current Assets of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹44,055.0 Cr | -0.2% | 20% | 62.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.2% |
20% |
62.9% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses